Results 11 to 20 of about 160,257 (342)

Platelet-Activating Factor-Receptor and Tumor Immunity. [PDF]

open access: yesJSM Cell Dev Biol, 2014
First described in 1972 by Benveniste and colleagues, platelet-activating factor (PAF) remains one of the potent phospholipid known to date. The role of PAF produced enzymatically in mediating diverse biological and pathophysiological processes including
Sahu RP, Konger RL, Travers JB.
europepmc   +4 more sources

Upregulated pneumococcal adhesion molecule (platelet-activating factor receptor) may predispose COPD patients to community-acquired pneumonia [PDF]

open access: yesInternational Journal of COPD, 2017
Shakti Dhar Shukla,1,2 Philip M Hansbro,1,2 Eugene Haydn Walters3 1School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2Hunter Medical Research Institute, New Lambton Heights, NSW, 3School of Medicine, University of ...
Shukla SD, Hansbro PM, Walters EH
doaj   +2 more sources

Platelet-activating factor receptor (PAFR) regulates neuronal maturation and synaptic transmission during postnatal retinal development [PDF]

open access: yesFrontiers in Cellular Neuroscience
IntroductionPlatelet-activating factor (PAF), PAF receptor (PAFR), and PAF- synthesis/degradation systems are involved in essential CNS processes such as neuroblast proliferation, differentiation, migration, and synaptic modulation.
Barbara Dalmaso   +5 more
doaj   +2 more sources

Nuclear localization of platelet activating factor receptor accounts for microglial phagocytosis in ischemic stroke

open access: goldNeurobiology of Disease
Ischemic stroke (IS) is a leading cause of global morbidity and mortality. A critical strategy for improving the prognosis of IS involves mitigating neuronal loss to enhance neuroplasticity, with microglia playing a vital role in neuronal survival.
Xi-Yue Zhang   +9 more
doaj   +2 more sources

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine

open access: yesCells, 2021
The platelet-activating factor receptor (PAFR) and its ligand (PAF) are important inflammatory mediators that are overexpressed in ovarian cancer. The receptor is an important player in ovarian cancer development.
Eileen Deuster   +14 more
doaj   +1 more source

The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism [PDF]

open access: yesZhongguo aizheng zazhi, 2021
Background and purpose: The current treatment of ovarian cancer is surgery and adjuvant platinum-based chemotherapy. However, relapse and drug resistance are common.
YU Yi, CONG Qing, XU Congjian, JIANG Wei
doaj   +1 more source

UVB-Induced Microvesicle Particle Release and Its Effects on the Cutaneous Microenvironment

open access: yesFrontiers in Immunology, 2022
Ultraviolet B radiation (UVB) has profound effects on human skin that results in a broad spectrum of immunological local and systemic responses and is the major cause of skin carcinogenesis.
Timothy C. Frommeyer   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy